Icecure Medical Analyst Ratings
Icecure Medical Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/06/2023 | 167.86% | HC Wainwright & Co. | → $3 | Reiterates | Buy → Buy |
| 08/15/2023 | 257.14% | Alliance Global Partners | $4.25 → $4 | Maintains | Buy |
| 08/15/2023 | 167.86% | HC Wainwright & Co. | → $3 | Reiterates | Buy → Buy |
| 07/25/2023 | 167.86% | HC Wainwright & Co. | → $3 | Reiterates | Buy → Buy |
| 06/01/2023 | 167.86% | HC Wainwright & Co. | → $3 | Reiterates | Buy → Buy |
| 05/23/2023 | 167.86% | HC Wainwright & Co. | → $3 | Reiterates | Buy → Buy |
| 03/28/2023 | 167.86% | HC Wainwright & Co. | → $3 | Reiterates | → Buy |
| 03/20/2023 | 167.86% | HC Wainwright & Co. | → $3 | Initiates Coverage On | → Buy |
| 10/25/2022 | 167.86% | Maxim Group | → $3 | Initiates Coverage On | → Buy |
| 02/02/2022 | 404.46% | Brookline Capital | → $5.65 | Initiates Coverage On | → Buy |
| 09/22/2021 | 1194.64% | Alliance Global Partners | → $14.5 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 09/06/2023 | 167.86% | HC Wainwright公司 | →$3 | 重申 | 購買→購買 |
| 2023年08月15日 | 257.14% | 聯盟全球合作夥伴 | $4.25→$4 | 維護 | 買 |
| 2023年08月15日 | 167.86% | HC Wainwright公司 | →$3 | 重申 | 購買→購買 |
| 07/25/2023 | 167.86% | HC Wainwright公司 | →$3 | 重申 | 購買→購買 |
| 06/01/2023 | 167.86% | HC Wainwright公司 | →$3 | 重申 | 購買→購買 |
| 2023年05月23日 | 167.86% | HC Wainwright公司 | →$3 | 重申 | 購買→購買 |
| 03/28/2023 | 167.86% | HC Wainwright公司 | →$3 | 重申 | →購買 |
| 03/20/2023 | 167.86% | HC Wainwright公司 | →$3 | 開始承保 | →購買 |
| 2022年10月25日 | 167.86% | Maxim集團 | →$3 | 開始承保 | →購買 |
| 02/02/2022 | 404.46% | 布魯克林資本 | →$5.65 | 開始承保 | →購買 |
| 09/22/2021 | 1194.64% | 聯盟全球合作夥伴 | →$14.5 | 開始承保 | →購買 |
What is the target price for Icecure Medical (ICCM)?
冰療醫療(ICCM)的目標價格是多少？
The latest price target for Icecure Medical (NASDAQ: ICCM) was reported by HC Wainwright & Co. on September 6, 2023. The analyst firm set a price target for $3.00 expecting ICCM to rise to within 12 months (a possible 167.86% upside). 9 analyst firms have reported ratings in the last year.
納斯達克(ICCM)的最新目標價是由HC Wainwright&Co.於2023年9月6日報道的。這家分析公司將目標價定為3美元，預計iccm將在12個月內上漲至(可能上漲167.86%)。去年有9家分析公司公佈了評級。
What is the most recent analyst rating for Icecure Medical (ICCM)?
冰療醫療(ICCM)的最新分析師評級是多少？
The latest analyst rating for Icecure Medical (NASDAQ: ICCM) was provided by HC Wainwright & Co., and Icecure Medical reiterated their buy rating.
冰療醫療(納斯達克代碼：ICCM)的最新分析師評級由HC Wainwright&Co.提供，冰療醫療重申其買入評級。
When is the next analyst rating going to be posted or updated for Icecure Medical (ICCM)?
IceCure Medical(ICCM)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Icecure Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Icecure Medical was filed on September 6, 2023 so you should expect the next rating to be made available sometime around September 6, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與IceCure Medical的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。IceCure Medical的上一次評級是在2023年9月6日提交的，所以你應該預計下一次評級將在2024年9月6日左右的某個時候提供。
Is the Analyst Rating Icecure Medical (ICCM) correct?
分析師對冰療醫療(ICCM)的評級正確嗎？
While ratings are subjective and will change, the latest Icecure Medical (ICCM) rating was a reiterated with a price target of $0.00 to $3.00. The current price Icecure Medical (ICCM) is trading at is $1.12, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的冰療醫療(ICCM)評級被重申，目標價在0.00美元至3.00美元之間。IceCure Medical(ICCM)目前的交易價格為1.12美元，在分析師的預測範圍內。
譯文內容由第三人軟體翻譯。